Íomhá chlúdaigh

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma

Jian-Hong Zhong,1,2 Bang-De Xiang,1,2 Le-Qun Li1,2 1Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People’s Republic of China; 2Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, People&...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Zhong JH (Údar), Xiang BD (Údar), Li LQ (Údar)
Formáid:	LEABHAR
Foilsithe / Cruthaithe:	Dove Medical Press, 2015-10-01T00:00:00Z.
Ábhair:	article
Rochtain ar líne:	Connect to this object online.
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis
de réir: Tian X, et al.
Foilsithe / Cruthaithe: (2015)

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
de réir: Jiwon Yang, et al.
Foilsithe / Cruthaithe: (2024)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
de réir: Hadeel A Helmi, et al.
Foilsithe / Cruthaithe: (2020)

Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
de réir: Zizhuo Wang, et al.
Foilsithe / Cruthaithe: (2024)

Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study
de réir: Pipit Burasakarn, et al.
Foilsithe / Cruthaithe: (2023)

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
de réir: Hiroki Higashihara, et al.
Foilsithe / Cruthaithe: (2021)

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
de réir: Toshiyuki Irie, et al.
Foilsithe / Cruthaithe: (2020)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
de réir: Liu KC, et al.
Foilsithe / Cruthaithe: (2020)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
de réir: Mahmoud Abu Elfadl, et al.
Foilsithe / Cruthaithe: (2019)

Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
de réir: Byeong Geun Song, et al.
Foilsithe / Cruthaithe: (2024)

Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
de réir: Guoliang Shao, et al.
Foilsithe / Cruthaithe: (2022)

The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
de réir: Zeng J, et al.
Foilsithe / Cruthaithe: (2023)

Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization
de réir: Li Q, et al.
Foilsithe / Cruthaithe: (2018)

Outcomes of conventional transarterial chemoembolization using guidance software for hepatocellular carcinoma in the caudate lobe of the liver
de réir: Shiro Miyayama, et al.
Foilsithe / Cruthaithe: (2023)

Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma
de réir: Xiang Li, et al.
Foilsithe / Cruthaithe: (2020)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
de réir: Won-Gyom Choe, et al.
Foilsithe / Cruthaithe: (2018)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
de réir: Won-Gyom Choe, et al.
Foilsithe / Cruthaithe: (2018)

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma
de réir: Ying He, et al.
Foilsithe / Cruthaithe: (2023)

Safety and Efficacy of Liver Venous Deprivation Following Transarterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma
de réir: Sy TV, et al.
Foilsithe / Cruthaithe: (2023)

The hepatitis B virus reactivation after transarterial chemoembolization in Chinese hepatocellular carcinoma patients with low serum hepatitis B virus DNA level
de réir: Shao W, et al.
Foilsithe / Cruthaithe: (2015)

Therapeutic efficacy and safety of Compound Kushen Injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis
de réir: Xiao eMa, et al.
Foilsithe / Cruthaithe: (2016)

Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
de réir: Yuri Cho, et al.
Foilsithe / Cruthaithe: (2023)

Implications of the first edition of the Korean expert consensus-based practice recommendations for transarterial chemoembolization in the management of hepatocellular carcinoma
de réir: Jin Wook Chung
Foilsithe / Cruthaithe: (2023)

The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma
de réir: Jae Min Park, et al.
Foilsithe / Cruthaithe: (2021)

Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients With Large Unresectable Hepatocellular Carcinoma
de réir: Haixia Zhang, et al.
Foilsithe / Cruthaithe: (2022)

Prognostic value of interleukin-10 and tumor necrosis factor-α polymorphisms in patients with hepatocellular carcinoma treated with transarterial chemoembolization
de réir: Ahmed A Ghafar, et al.
Foilsithe / Cruthaithe: (2019)

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
de réir: Sujin Jin, et al.
Foilsithe / Cruthaithe: (2023)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
de réir: Su Jong Yu, et al.
Foilsithe / Cruthaithe: (2023)

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma
de réir: Chiu SH, et al.
Foilsithe / Cruthaithe: (2020)

Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis
de réir: Liyan Huang, et al.
Foilsithe / Cruthaithe: (2023)

Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
de réir: Tae Hoon Kim, et al.
Foilsithe / Cruthaithe: (2021)

Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study
de réir: Tang CW, et al.
Foilsithe / Cruthaithe: (2016)

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies
de réir: Theresa H. Wirtz, et al.
Foilsithe / Cruthaithe: (2021)

Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients
de réir: Guangsheng Zhao, et al.
Foilsithe / Cruthaithe: (2021)

Superselective transarterial radioembolization for the treatment of hepatocellular carcinoma
de réir: Gyoung Min Kim
Foilsithe / Cruthaithe: (2021)

Efficacy of lenvatinib combined with sequential transarterial chemoembolization for primary hepatocellular carcinoma and the effects on serum basic fibroblast growth factor and vascular endothelial growth factor
de réir: Qing-Yun Xie, et al.
Foilsithe / Cruthaithe: (2022)

A comprehensive discharge planning program on fatigue and functional status of patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A randomized clinical controlled trial
de réir: Nawiya Yenjai, et al.
Foilsithe / Cruthaithe: (2022)

Safety and Efficacy of Selective Internal Radionuclide Therapy with <sup>90</sup>Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization
de réir: Alexander Bellendorf, et al.
Foilsithe / Cruthaithe: (2024)

Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
de réir: Degang Kong, et al.
Foilsithe / Cruthaithe: (2020)

Biliary complications after transcatheter arterial chemoembolization for hepatocellular carcinoma
de réir: Yoon Suk Lee, et al.
Foilsithe / Cruthaithe: (2020)